Total submissions: 9
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Ce |
RCV000585037 | SCV000692875 | likely benign | not provided | 2024-05-01 | criteria provided, single submitter | clinical testing | ZNF469: BP4, BS2 |
Gene |
RCV000585037 | SCV000730236 | likely benign | not provided | 2021-05-20 | criteria provided, single submitter | clinical testing | This variant is associated with the following publications: (PMID: 26964041) |
Labcorp Genetics |
RCV000585037 | SCV002389569 | benign | not provided | 2025-01-27 | criteria provided, single submitter | clinical testing | |
Genome- |
RCV002245024 | SCV002514272 | benign | Brittle cornea syndrome 1 | 2021-12-05 | criteria provided, single submitter | clinical testing | |
Genome Diagnostics Laboratory, |
RCV002279367 | SCV002565323 | likely benign | Ehlers-Danlos syndrome | 2022-06-06 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV002325117 | SCV002611022 | likely benign | Cardiovascular phenotype | 2018-12-30 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Genome Diagnostics Laboratory, |
RCV000585037 | SCV001809693 | likely benign | not provided | no assertion criteria provided | clinical testing | ||
Clinical Genetics DNA and cytogenetics Diagnostics Lab, |
RCV001727766 | SCV001968844 | benign | not specified | no assertion criteria provided | clinical testing | ||
Prevention |
RCV003935582 | SCV004748823 | likely benign | ZNF469-related disorder | 2020-03-16 | no assertion criteria provided | clinical testing | This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). |